Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 7977 - 7984 of 12107 results

States’ Efforts for Drug Price Transparency Stymied by the Pharmaceutical Industry
August 2, 2016| Blog| Viewpoint

I-526 Processing Delays Expected to Continue into 2017
August 2, 2016| Blog| Viewpoint

Massachusetts Legislature Passes Clean Energy Legislation
August 2, 2016| Alert| Viewpoint

California Wrestles with Challenges to Meet the State’s Renewable Energy Goals
August 1, 2016| Blog| Viewpoint

Ninth Circuit Provides Clarification Concerning the Definition of Trade Secret
August 1, 2016| Blog| Viewpoint

OIG Gives Green Light to Hospice Provider’s Payment to Nursing Facilities
August 1, 2016| Blog| Viewpoint

FTC Plants A Flag With LabMD Ruling: What This Means for Enforcement
August 1, 2016| Blog| Viewpoint

"Privacy Shield" Open For Business - Fees?
August 1, 2016| Blog| Viewpoint
News & Press Releases
Mintz Honored with NLADA Beacon of Justice Award
August 21, 2025
Mintz will receive a 2025 Beacon of Justice Award from the National Legal Aid & Defender Association (NLADA) for efforts to sustain equal justice for families and communities. This is the sixth consecutive year that Mintz has won this award.
SEC’s Pharmaceutical Insider Trading Case Yields Quick Deals
August 19, 2025
Bloomberg Law featured a statement from Member Jason P.W. Halperin in its coverage of a pharmaceutical insider trading case brought by the SEC. Jason and the Mintz team of Sean Prosser and Elizabeth Platonova represented Robert Yedid in reaching a resolution in which the client pled guilty and, along with the other defendants, entered into consent orders with the SEC.
Mintz Advises Oppenheimer & Co. and Initial Purchasers in $475M Convertible Senior Notes Offering by WisdomTree
August 19, 2025
Mintz represented Oppenheimer & Co., as sole book-running manager, and Craig-Hallum Capital Group and Northland Securities, as co-managers, in the private placement of $475 million aggregate principal amount of 4.625% Convertible Senior Notes due 2030 issued by WisdomTree, Inc (NYSE: WT) (“WisdomTree”). The notes were sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933.
Events
Podcasts

Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
